Expansion of <i><scp>BCR</scp>/<scp>ABL</scp>1</i><sup>+</sup> cells requires <scp>PAK</scp>2 but not <scp>PAK</scp>1Leo Edlinger, Andrea Hoelbl‐Kovacic, Georg Greiner et al.|British Journal of Haematology|2017Cited by 17
122P Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experienceFlorian Moik, Philipp J. Jost, Jakob M. Riedl et al.|Annals of Oncology|2024Cited by 0